Monday, June 15, 2026

ROCKET Race Front New COLD War: US Panic Over China’s Lunar Deadline Proves We Are Losing The Battle For Space

SpaceX proposes a streamlined lunar mission to address NASA's concerns over Starship delays, aiming for a faster return to the Moon.

What If OpenAI Owned Chrome? The Company Says It’s Interested

OpenAI is interested in acquiring Google Chrome if it's sold, as confirmed during an antitrust trial regarding Google's market monopoly.

Yoon Suk Yeol’s Legal Team Seeks to End His Detention Amid Rebellion Charges

Court to decide on President Yoon Suk Yeol's arrest cancellation amid rebellion charges; unprecedented case in South Korean history.

Tag: development

North KoreaKoreaKimMilitaryAISouth KoreamarketrelationsInternational

Eli Lilly vs. Novo Nordisk: A $1.2 Billion Bet Reveals Two Very Different Futures for Obesity Drugs

Eli Lilly and Novo Nordisk are pursuing different strategies in the obesity treatment market, focusing on expansion versus core strengths.

Why Ebola Now? SK Bioscience Joins a $30 Million Global Push to Rethink Ebola Vaccine Production

SK Bioscience secures funding to enhance Ebola vaccine production, improving yield and stability for better accessibility amid outbreaks.

Unlocking the Future: How Neuracle Science’s NS101 is Set to Revolutionize Alzheimer’s Treatment by 2030

Neuracle Science aims for a KOSDAQ listing and focuses on developing NS101 for neurological diseases, attracting global interest.

Unlocking the Future of Health Supplements: HLB Global and Nodcure’s Game-Changing Partnership

HLB Global partners with Nodcure for joint development of next-gen health supplements, aiming to innovate and expand market reach.

How SK Bioscience Plans to Dominate the Global Vaccine Market in 2026

SK Bioscience enhances its operational system with new COO and key appointments to boost global competitiveness and vaccine development.

Revolutionizing Pharma: How LG CNS’s Agentic AI is Set to Transform Drug Development in South Korea

LG CNS expands its AI Transformation business into pharma, enhancing drug development with AI-driven platforms and automation services.

From Hair Loss to Inflammation: JW Pharmaceutical Showcases Pipeline to Global Pharma at JPMorgan

JW Pharmaceutical participated in the JP Morgan Healthcare Conference, discussing potential drug partnerships and licensing deals.

GI Innovation Uses AI to Develop Next-Gen Allergy Drug Aimed at Dupixent’s $15 Billion Market

GI Innovation is advancing an AI-optimized allergy treatment, targeting multiple pathways in atopic dermatitis to rival Dupixent.

Is DD01 the Future of MASH Treatment? Insights from D&D Pharmatech’s JP Morgan Presentation

D&D Pharmatech's CEO highlights growth in K-bio at JPM Healthcare Conference, unveiling promising drug data and future plans for clinical trials.

Nvidia and Eli Lilly: How AI is Revolutionizing Drug Development in 2026

Nvidia partners with Eli Lilly to enhance AI in drug development, aiming to revolutionize the biotech industry.

How Celltrion Plans to Expand Its Biosimilar Portfolio to 41 Products by 2038

Celltrion unveils its growth strategy at the JP Morgan Healthcare Conference, aiming to expand biosimilars and develop new drug pipelines.

2026: South Korea’s Advanced Regenerative Medicine R&D Investment Expands – What You Need to Know!

The Ministry of Health and Welfare aims to boost investments in advanced regenerative medicine R&D and improve research infrastructure in South Korea.

Revolutionizing Drug Development: Ewha Womans University Partners with Cureverse for AI-Powered Innovations

Ewha Womans University and Cureverse Inc. partner for AI-driven drug development, focusing on collaboration and expert training.

Google’s Quantum Leap: How the ‘Willow’ Chip Reduces Errors in Quantum Computing

Google advances quantum computing with its Willow chip, reducing errors and demonstrating OTOC measurements, enhancing commercial viability.

Top News

- Our Sponsors Ad -

Follow us

Cars

Tech

future

health

© Copyright by News1. All Rights Reserved.